Medicare Enrolled

Dr. Sherry Jose, MD

Pain Medicine · Upland, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
30 MEDICAL CENTER BLVD, Upland, PA 19013
6108746448
In practice since 2005 (21 years)
NPI: 1922006600 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jose from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jose? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jose

Dr. Sherry Jose is a pain medicine specialist in Upland, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Jose performed 3,808 Medicare services across 1,399 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jose received a total of $6,226 from 34 pharmaceutical and/or device companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jose is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 8% volume in PA $6,226 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,808
Medicare services
Top 8% in PA for pain medicine
1,399
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~181 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
1,582 $61 $701
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
857 $98 $325
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
630 $71 $250
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
314 $50 $340
Principal care management for high-risk disease, first 30 minutes
This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month.
141 $59 $450
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
45 $130 $700
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
39 $218 $3,615
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
37 $251 $6,016
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
34 $186 $3,719
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
34 $102 $3,719
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
25 $162 $4,080
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
25 $429 $3,960
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
24 $213 $4,000
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
21 $94 $4,200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,226
Total received (2018-2024)
Avg $889/year across 7 years
Top 19% in PA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
243
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,167 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$58 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,095
2023
$1,235
2022
$1,427
2021
$1,043
2020
$272
2019
$16
2018
$139

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Nalu Medical, Inc.
$541
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$470
SCILEX PHARMACEUTICALS INC.
$258
Abbott Laboratories
$218
Collegium Pharmaceutical, Inc.
$207
Forte Bio-Pharma LLC
$137
Boston Scientific Corporation
$133
Nevro Corp.
$40
VERTEX PHARMACEUTICALS INCORPORATED
$29
Vertos Medical, Inc.
$21
PFIZER INC.
$21
Valinor Pharma, LLC
$19
Top 3 companies account for 60.5% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$891
Boston Scientific Corporation
$742
Abbott Laboratories
$732
Nalu Medical, Inc.
$568
Nevro Corp.
$561
Collegium Pharmaceutical, Inc.
$479
BOSTON SCIENTIFIC CORPORATION
$293
SCILEX PHARMACEUTICALS INC.
$270
GRT US Holding, Inc.
$184
Scilex Pharmaceuticals Inc.
$182
Forte Bio-Pharma LLC
$179
PROTEGA PHARMACEUTIALS INC
$143
SPR Therapeutics, Inc
$110
Curonix LLC
$107
Zimmer Biomet Holdings, Inc.
$101
Lilly USA, LLC
$98
SI-BONE, Inc.
$92
BioDelivery Sciences International, Inc.
$58
Almatica Pharma LLC
$45
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$41
Biohaven Pharmaceuticals, Inc.
$40
Mindray DS USA, Inc.
$40
Stimwave Technologies Incorporated
$31
VERTEX PHARMACEUTICALS INCORPORATED
$29
Biohaven Pharmaceutical Holding Company Ltd.
$26
Pacira Pharmaceuticals Incorporated
$25
Medtronic, Inc.
$24
Fidia Pharma USA Inc.
$23
Biogen, Inc.
$22
Vertos Medical, Inc.
$21
PFIZER INC.
$21
Valinor Pharma, LLC
$19
Electronic Waveform Lab, Inc.
$14
Zyla Life Sciences, Inc.
$13
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
A7 ANESTHESIA SYSTEM · AXIUM · BELBUCA · Belbuca · Comprehensive · ETERNA · Freelink · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · HYMOVIS · INFINION · INTELLIS · Iovera · MOUNJARO · MOVANTIK · NALOCET · NURTEC ODT · Nalu Neurostimulation System · Omnia · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim IPG · Qutenza · RELISTOR · ROXYBOND · SPECTRA WAVEWRITER · SPINRAZA · SPRINT PNS System · SPRIX · Senza · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Upland?
Compare pain medicines in the Upland area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
78
Per 100K population
13.5
County median income
$88,576
Nearest hospital
CROZER CHESTER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jose is a clinical cardiology specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement in the top 19% of PA peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jose experienced with drug screening test?
Based on Medicare claims data, Dr. Jose performed 1,582 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jose receive payments from pharmaceutical companies?
Yes. Dr. Jose received a total of $6,226 from 34 companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jose's costs compare to other pain medicines in Upland?
Dr. Jose's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jose) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →